{"nct_id":"NCT00954915","title":"Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis","status":"TERMINATED","status_verified_date":"2022-01","start_date":"2009-12","start_date_type":null,"primary_completion_date":"2010-07","primary_completion_date_type":"ACTUAL","completion_date":"2010-07","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MGNX"]}